Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated potassium channel Kv1.1 is a key regulator of neuronal excitability, primarily expressed in the central nervous system. It contributes to action potential repolarization and controls neuronal firing frequency. Mutations or autoimmune reactions against Kv1.1 can cause neurological disorders such as Episodic Ataxia type 1 and Isaacs syndrome. Channel activity is modulated by small molecules, such as niflumic acid, and is sensitive to stoichiometry/arrangement within heteromeric complexes.
Modulation of channel gating kinetics and open probability
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated Potassium Channel Subfamily A Member 1 (Kv1.1).